Share the Science: Dr. Koen Van Besien talks haplo-cord blood transplants for HIV & more

Save the Cord Foundation and WellSky are proud to welcome Dr. Koen van Besien as our featured speaker for the next edition of Share the Science on Tuesday, March 29th at 2pm US Eastern Time / 11am US Pacific Time. Join us to hear Dr. Koen van Besien from Seidman Cancer Center at University Hospital (Cleveland, Ohio) discuss innovations in cord blood transplants, including haplo-cord transplants for HIV, leukemia and more.

RECORDING AVAILABLE. Click to view via the Share the Science Archive.

Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field.  As always, we invite both health professionals and the general public to join us for this unique online educational series. Learn more about this exciting educational series here.

The Enduring Promise of Cord Blood:
​HIV, Leukemia & Beyond

For almost 40 years, cord blood transplants have been used in the treatment of more than 80 different life-threatening diseases, most notably leukemia and lymphoma. In recent years, transplant doctors and researchers have pushed cord blood well beyond traditional transplant. In particular, there has been an interest in further refining the cord blood transplant process through various manipulations and combinations so as to better respond to a particular patient's needs and to ultimately expand access and improve outcomes. Dr. van Besien has been a leading figure in this research.

For this exclusive webinar, we have asked Dr. van Besien to tell us about the use of cord blood for his transplant patients and to discuss its advantages/disadvantages when compared to other stem cell sources. In addition, Dr. van Besien will discuss his research regarding the innovation of haplo-cord transplants and how this new process could help expand access and improve outcomes for certain high risk patients. In particular, he will discuss the use of cord blood in the treatment of HIV (namely the New York Patient) and in the mangement of hematological malignancies.

Important topics Dr. van Besien will cover include:

• The role of donor choice in transplant outcomes.
• The potential advantages of umbilical cord blood in disease control.
• The role umbilical cord blood can play in transplants for adults.
• Important research on HIV (New York Patient) and umbilical cord blood stem cell transplants.

SHARE THE SCIENCE
with
Dr. Koen van Besien
Blood and Marrow Transplant Division Chief,
Seidman Cancer Center at University Hospital in Cleveland, Ohio
 
"The Enduring Promise of Cord Blood" 
Free webinar.  Open to the public.
​
Wednesday, March 29th 2pm US Eastern Time / 11am US Pacific Time

RECORDING NOW AVAILABLE
via the Share the Science Archive

Watch the RECORDING via the Share the Science Archive: Dr. Koen van Besien

About the speaker

Dr. Koen van Besien
​
Blood and Marrow Transplant Division Chief,
Seidman Cancer Center at University Hospital

With an established reputation for clinical research and care, Dr. van Besien has made numerous contributions to the field of cellular therapy and stem cell transplantation. Most recently, he has focused on methods to extend the use of transplantation to more patients in need. His group has recently reported the first successful transplant for a patient with HIV and leukemia using a haplo-cord graft - a unique procedure developed by his team. The patient remains free of HIV and leukemia more than four years after transplant.

---

We wish to thank Dr. Koen van Besien for volunteering his time to speak on
Share the Science and sharing his valuable insight
on the use of haplo-cord blood transplants in the treatment of HIV, leukemia and more.
​​
We also wish to also thank our generous sponsor and partner for this event,
WellSky Health, who continue to support cord blood
education through our “Share the Science” series.